University of Massachusetts Medical School, Worcester, MA (HJ-B); Massachusetts General Hospital, Boston, MA (LJ); and Yale University School of Medicine, New Haven, CT (HJ-B, AJA).
J Addict Med. 2019 Jan/Feb;13(1):23-27. doi: 10.1097/ADM.0000000000000444.
: Topiramate is an anticonvulsant medication with increasingly strong evidence, supporting its use for treating alcohol use disorder (AUD) based on clinical trials. These clinical cases summarize the initiation and titration of topiramate in AUD treatment. The core issues of patient selection, consideration of comorbid psychiatric and medical conditions, side-effect profile, safety and effectiveness are reviewed. Addiction physicians should take a leading role in using topiramate to treat AUDs, working with patients to balance the benefits of topiramate with the risk.
: 托吡酯是一种抗惊厥药物,越来越多的证据支持其用于治疗酒精使用障碍(AUD),这基于临床试验。这些临床病例总结了托吡酯在 AUD 治疗中的起始和滴定。本文回顾了患者选择的核心问题、合并精神和医学疾病的考虑因素、副作用概况、安全性和有效性。成瘾医师应在使用托吡酯治疗 AUD 方面发挥主导作用,与患者合作,平衡托吡酯的益处与风险。